OBJECTIVE: To develop a self-report measure of barriers to adherence and to evaluate its reliability and validity in a sample of adolescents with asthma. METHODS: The Illness Management Survey (IMS) was developed through item generation, expert panel review, and focus group administration. Adolescents with asthma (N = 152) completed the measure. Participants reported on perceived drawbacks to medication, risk-taking behavior, and social desirability tendencies. Providers rated adolescents' illness severity and adherence. Reliability and validity of the IMS were assessed, and factor structure was examined. RESULTS: The 27-item IMS shows high internal consistency (alpha =.87). Scores correlate with perceived medication drawbacks, risk taking, and self- and provider reports of adherence. Principal-components analysis indicates five domains of barriers, accounting for 52.4% of the variance: disease/regimen issues, cognitive difficulties, lack of social support/lack of self-efficacy, denial/distrust, and peer/family issues. CONCLUSIONS: Preliminary data indicate that the IMS reliably and validly assesses perceived barriers to adherence within this sample of adolescents with asthma. It shows promise as a tool for identifying subgroups of nonadherent adolescents.
OBJECTIVE: To develop a self-report measure of barriers to adherence and to evaluate its reliability and validity in a sample of adolescents with asthma. METHODS: The Illness Management Survey (IMS) was developed through item generation, expert panel review, and focus group administration. Adolescents with asthma (N = 152) completed the measure. Participants reported on perceived drawbacks to medication, risk-taking behavior, and social desirability tendencies. Providers rated adolescents' illness severity and adherence. Reliability and validity of the IMS were assessed, and factor structure was examined. RESULTS: The 27-item IMS shows high internal consistency (alpha =.87). Scores correlate with perceived medication drawbacks, risk taking, and self- and provider reports of adherence. Principal-components analysis indicates five domains of barriers, accounting for 52.4% of the variance: disease/regimen issues, cognitive difficulties, lack of social support/lack of self-efficacy, denial/distrust, and peer/family issues. CONCLUSIONS: Preliminary data indicate that the IMS reliably and validly assesses perceived barriers to adherence within this sample of adolescents with asthma. It shows promise as a tool for identifying subgroups of nonadherent adolescents.
Authors: Michael Seid; Elizabeth J D'Amico; James W Varni; Jennifer K Munafo; Maria T Britto; Carolyn M Kercsmar; Dennis Drotar; Eileen C King; Lynn Darbie Journal: J Pediatr Psychol Date: 2011-12-13
Authors: Kevin A Hommel; Michele Herzer; Lisa M Ingerski; Elizabeth Hente; Lee A Denson Journal: J Pediatr Gastroenterol Nutr Date: 2011-10 Impact factor: 2.839
Authors: Kevin A Hommel; Julia Carmody; Andrew D Hershey; Christina Holbein; Marielle Kabbouche-Samaha; James Peugh; Scott Powers Journal: Headache Date: 2020-04-22 Impact factor: 5.887
Authors: Kevin A Hommel; Elizabeth Hente; Michele Herzer; Lisa M Ingerski; Lee A Denson Journal: Eur J Gastroenterol Hepatol Date: 2013-04 Impact factor: 2.566
Authors: Elizabeth D Cox; Katie A Fritz; Kristofer W Hansen; Roger L Brown; Victoria Rajamanickam; Kaelyn E Wiles; Bryan H Fate; Henry N Young; Megan A Moreno Journal: Diabetes Res Clin Pract Date: 2014-01-18 Impact factor: 5.602